Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Valganciclovir/Ganciclovir
DRUG
2 trials
Sponsors
University Hospital Birmingham NHS Foundation Trust
, University Health Network, Toronto
Conditions
CMV
Critical Illness
Lung Transplant Recipient
Phase 2
Cytomegalovirus Control in Critical Care
Completed
NCT01503918
University Hospital Birmingham NHS Foundation Trust
Critical Illness
Start: 2012-01-31
End: 2014-03-31
Updated: 2015-01-12
Phase 4
Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients
Recruiting
NCT07235683
University Health Network, Toronto
CMV, Lung Transplant Recipient
Start: 2025-12-24
End: 2027-08-01
Target: 40
Updated: 2026-02-17
Related Papers
Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients
JAMA Internal Medicine
2017-04-24
96 citations